Monoclonal and polyclonal humoral immune response to EC HER‐2/NEUpeptides with low similarity to the host's proteome
Open Access
- 6 February 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 98 (5) , 741-747
Abstract
We are studying peptide immunogenicity as a function of the similarity level to the host's proteome. By using as a model the breast/prostate cancer‐associated HER‐2/neuantigen, we analyzed the monoclonal and polyclonal humoral immune responses against HER‐2/neupeptide motifs not shared with the host proteome. We show here that(i)a mouse monoclonal antibody (MAb) raised against the extracellular domain (EC) of human HER‐2/neu oncoprotein recognized a linear peptide motif endowed with low similarity level to the mouse proteome;(ii)likewise, human sera from breast/prostate cancer patients preferentially recognized peptide fragments from the EC of the HER‐2/neuoncoprotein having sequences that are not present in the human proteome. Together with previous results obtained in other disease models (cervical cancer‐associated HPV16 E7 oncoprotein andPemphigus vulgarisauto‐antigen desmoglein‐3), the present data suggest that a low level of sequence similarity to the host's proteome might be an important factor in shaping the pool of B cell epitopes.Keywords
This publication has 29 references indexed in Scilit:
- Computer‐assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequencesImmunology & Cell Biology, 2000
- A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptorsOncogene, 1997
- Interactions of protein antigens with antibodies.Proceedings of the National Academy of Sciences, 1996
- Tolerance and Cancer: A Critical Issue in Tumor ImmunologyCritical Reviews™ in Oncogenesis, 1996
- In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stabilityVaccine, 1995
- Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage‐displayed peptidesEuropean Journal of Immunology, 1994
- Mechanisms of T cell recognition with application to vaccine designMolecular Immunology, 1991
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- Protein Antigenic Structures Recognized by T Cells; Potential Applications to Vaccine DesignImmunological Reviews, 1987
- T-cell antigenic sites tend to be amphipathic structures.Proceedings of the National Academy of Sciences, 1985